0.6614
price up icon5.99%   0.0374
after-market Dopo l'orario di chiusura: 29.72 29.06 +4,393%
loading

Relmada Therapeutics Inc Azioni (RLMD) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
43.90%
10.22
18.22 19.08 23.01 18.82
Operating Income/Loss
43.90%
-10.22
-18.22 -19.08 -23.01 -18.82
Nonoperating Income/Loss
46.15%
0.3549
0.659 0.4184 1.2829 1.0507
Income/Loss From Continuing Operations Before Tax
43.81%
-9.8664
-17.56 -18.66 -21.73 -17.77
Income/Loss From Continuing Operations After Tax
43.81%
-9.8664
-17.56 -18.66 -21.73 -17.77
Net Income/Loss
43.81%
-9.8664
-17.56 -18.66 -21.73 -17.77
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
9.15%
33.19
30.41 0.00351 30.17 30.17
Diluted Average Shares
9.15%
33.19
30.41 0.00351 30.17 30.17
Basic Earnings Per Share
48.28%
-0.30
-0.58 -0.62 -0.72 -0.59
Diluted Earnings Per Share
48.28%
-0.30
-0.58 -0.62 -0.72 -0.59
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$24.54
price up icon 0.95%
$84.00
price down icon 0.90%
$26.98
price up icon 2.70%
$104.79
price down icon 0.27%
$132.17
price up icon 3.00%
biotechnology ONC
$308.91
price up icon 0.09%
Capitalizzazione:     |  Volume (24 ore):